438 related articles for article (PubMed ID: 12454801)
1. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
[TBL] [Abstract][Full Text] [Related]
2. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
[TBL] [Abstract][Full Text] [Related]
3. The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.
Laitman Y; Herskovitz L; Golan T; Kaufman B; Paluch SS; Friedman E
Fam Cancer; 2012 Jun; 11(2):243-7. PubMed ID: 22219001
[TBL] [Abstract][Full Text] [Related]
4. The HNPCC associated MSH2*1906G-->C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population.
Sun S; Greenwood CM; Thiffault I; Hamel N; Chong G; Foulkes WD
J Med Genet; 2005 Oct; 42(10):766-8. PubMed ID: 16199548
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
[TBL] [Abstract][Full Text] [Related]
6. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
Guillem JG; Glogowski E; Moore HG; Nafa K; Markowitz AJ; Shia J; Offit K; Ellis NA
Ann Surg; 2007 Apr; 245(4):560-5. PubMed ID: 17414604
[TBL] [Abstract][Full Text] [Related]
7. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
[TBL] [Abstract][Full Text] [Related]
8. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
9. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
[TBL] [Abstract][Full Text] [Related]
10. An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.
Goldberg Y; Porat RM; Kedar I; Shochat C; Galinsky D; Hamburger T; Hubert A; Strul H; Kariiv R; Ben-Avi L; Savion M; Pikarsky E; Abeliovich D; Bercovich D; Lerer I; Peretz T
Fam Cancer; 2010 Jun; 9(2):141-50. PubMed ID: 19851887
[TBL] [Abstract][Full Text] [Related]
11. Lynch Syndrome in high risk Ashkenazi Jews in Israel.
Goldberg Y; Kedar I; Kariiv R; Halpern N; Plesser M; Hubert A; Kaduri L; Sagi M; Lerer I; Abeliovich D; Hamburger T; Nissan A; Goldshmidt H; Solar I; Geva R; Strul H; Rosner G; Baris H; Levi Z; Peretz T
Fam Cancer; 2014 Mar; 13(1):65-73. PubMed ID: 23990280
[TBL] [Abstract][Full Text] [Related]
12. A636P testing in Ashkenazi Jews.
Guillem JG; Moore HG; Palmer C; Glogowski E; Finch R; Nafa K; Markowitz AJ; Offit K; Ellis NA
Fam Cancer; 2004; 3(3-4):223-7. PubMed ID: 15516845
[TBL] [Abstract][Full Text] [Related]
13. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
[TBL] [Abstract][Full Text] [Related]
15. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.
Mukherjee B; Rennert G; Ahn J; Dishon S; Lejbkowicz F; Rennert HS; Shiovitz S; Moreno V; Gruber SB
Gastroenterology; 2011 Jun; 140(7):1919-26. PubMed ID: 21419771
[TBL] [Abstract][Full Text] [Related]
16. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.
Lynch HT; Coronel SM; Okimoto R; Hampel H; Sweet K; Lynch JF; Barrows A; Wijnen J; van der Klift H; Franken P; Wagner A; Fodde R; de la Chapelle A
JAMA; 2004 Feb; 291(6):718-24. PubMed ID: 14871915
[TBL] [Abstract][Full Text] [Related]
17. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
18. MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.
Chan TL; Chan YW; Ho JW; Chan C; Chan AS; Chan E; Lam PW; Tse CW; Lee KC; Lau CW; Gwi E; Leung SY; Yuen ST
Am J Hum Genet; 2004 May; 74(5):1035-42. PubMed ID: 15042510
[TBL] [Abstract][Full Text] [Related]
19. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
[TBL] [Abstract][Full Text] [Related]
20. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS
Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
